In this paper, a hybrid heuristic rule-based and deterministic optimization-driven process decision framework is presented for the analysis and optimization of process flowsheets for end-to-end optimal (E2E0) pharmaceutical manufacturing. The framework accommodates various operating modes, such as batch, semi-batch and continuous, for the different unit operations that implement each manufacturing step. To address the challenges associated with solving process synthesis problems using a simulation-optimization approach, heuristic-based process synthesis rules are employed to facilitate the reduction of the superstructure into smaller sub-structures that can be more readily optimized. The practical application of the framework is demonstrated through a case study involving the end-to-end continuous manufacturing of an anti-cancer drug, lomustine. Alternative flowsheet structures are evaluated in terms of the sustainability metric, E-factor while ensuring compliance with the required production targets and critical product quality attributes.
No takes yet. Share an insight, caveat, or question.
Barhate et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: